Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis

Digestive Diseases and Sciences

Volumn 59, Issue 1, 2014, Pages 135-145

  Truta, Brindusa ^a   Li, Dan X ^b   Mahadevan, Uma ^a   Fisher, Elena R ^a   Chen, Yunn Y ^a   Grace, Kim ^a   Velayos, Fernando ^a   Terdiman, Jonathan P ^a  

^a Kaiser Permanente Santa Clara ^*  (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

ASCA; CBir1; Crohn's disease; Ileal pouch anal anastomosis; OmpC; pANCA

Indexed keywords

MARKER;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE COURSE; ELECTRONIC MEDICAL RECORD; ENDOSCOPY; FAMILY HISTORY; FEMALE; HUMAN; HUMAN EXPERIMENT; ILEITIS; ILEOANAL ANASTOMOSIS; MALE; NEUTROPHIL; OUTER MEMBRANE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SCHOOL CHILD; SEROLOGY; TOTAL COLON RESECTION; ULCERATIVE COLITIS; YOUNG ADULT;

EID: 84893703676     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2866-8     Document Type: Article

References (33)

1. Parks AG, Nicholls RJ. Proctocolectomy without ileostomy for ulcerative colitis. Br Med J. 1978;2:85-88.
2. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222:120-127.
3. Carmon E, Keidar A, Ravid A, et al. The correlation between quality of life and functional outcome in ulcerative colitis patients after proctocolectomy ileal pouch anal anastomosis. Colorectal Dis. 2003;5:228-232.
4. Delaney CP, Remzi FH, Gramlich T, et al. Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis. Ann Surg. 2002;236:43-48.
5. Hahnloser D, Pemberton JH, Wolf BG, et al. Results at up to 20 years after ileal pouch-anastomosis for chronic ulcerative colitis. Br J Surg. 2007;94:333-340.
6. Hueting WE, Buskens E, van der Tweel I, et al. Results and complications after ileal pouch anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dis Surg. 2005;22:69-79.
7. Stein RB, Lichtenstein GR. Complications after ileal pouch anastomosis. Semin Gastroeintest Dis. 2000;11:2-9.
8. Brown CJ, Maclean AR, Cohen Z, et al. Crohn's disease and indeterminate colitis and the ileal pouch anastomosis: outcomes and patterns of failure. Dis Colon Rectum. 2005;48:1542-1549.
9. Peyregne V, Francois Y, Gilly FN, et al. Outcome of ileal pouch secondary diagnosis of Crohn's disease. Int J Colorectal Dis. 2000;15:49-53.
10. Braveman JM, Schoetz DJ Jr, Marcello PW, et al. The fate of the ileal pouch in patients developing Crohn's disease. Dis Colon Rectum. 2004;47:1613-1619.
11. Reese GE, Lovergrove RE, Tilney HS, et al. The effect of Crohn's disease on outcomes after restorative proctocolectomy. Dis Colon Rectum. 2007;50:239-250.
12. Shen B, Fazio VW, Remzi FH, et al. Risk factors for disease of ileal pouch-anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol. 2006;4:81-89.
13. Koltun WA, Schoetz DJ Jr, Roberts PL, et al. Indeterminate colitis predispose to perineal complications after ileal pouch anastomosis. Dis Colon Rectum. 1991;34:857-860.
14. Melmed GY, Fleshner PR, Bardakcioglu O, et al. Familial history and serology predict Crohn's disease after ileal pouch-anal anastomosis for the ulcerative colitis. Dis Colon Rectum. 2008;51:100-108.
15. Peyrin-Biroulet L, Standaert-Vitse A, Branche J, et al. IBD serological panels: facts and perspectives. Inflamm Bowel Dis. 2007;13:1561-1566.
16. Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86:202-210.
17. Oudkerk Pool M, Ellenbroek PM, Ridwan BU, et al. Serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut. 1993;34:46-50.
18. Vasiliauskas E. Serum Immune Markers in Inflammatory Bowel Disease. Gastroenterol Endosc News October 1997.
19. Quinton JF, Sendid B, Reurnaux D, et al. Anti-Saccharomyces cerevisiae mannam antibodies with antineutrophil cytoplasmic antibodies in inflammatory bowel disease: prevalence and diagnosis role. Gut. 1998;42:788-791.
20. Peeters M, Joossens S, Vermeire S, et al. Diagnosis value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730-734.
21. Reese GE, Constantinides VA, Simillis C, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol. 2006;101:2410-2422.
22. Vasiliauskas EA, Plevy SF, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology. 1996;110:1810-1819.
23. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123:689-699.
24. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest. 2004;113:1296-1306.
25. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005;128:2020-2028.
26. Dendrinos KG, Becker JM, Stucchi AF, et al. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. J Gastrointest Surg. 2006;10:1060-1064.
27. Fleshner P, Ippoliti A, Dubinsky M, et al. Both preoperative pANCA and anti-CBir1 expression in ulcerative colitis influence pouchitis development after ileal-pouch anastomosis. Clin Gastroenterol Hepatol. 2008;6(5):561-568.
28. Tyler AD, Milgrom R, Xu W, et al. Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2012;10(5):507.e1-512.e1.
29. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Monterey: Wadsworth & Brooks/Cole; 1984.
30. Winstanley C, Morgan JAW. The bacterial flagellin gene as a biomarker for detection, population genetics and epidemiological analysis. Microbiology. 1997;143:3071-3084.
31. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410:1099-1103.
32. Toiyama Y, Araki T, Yoshiyama S, et al. The expression patterns of toll like receptor s in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg Today. 2006;36:287-290.
33. Papadakis AK, Yang H, Ippoliti A. Anti-Flagellin (Cbir1) phenotypic and genetic Crohn's associations. Inflamm Bowel Dis. 2007;13:524-530.